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Introduction
Radiation therapy including external radiotherapy and brachyther-apy is an indispensable part of cancer treatment modalities, with more than half of all cancer patients who have undergone radio-
therapy. This includes millions of people around the world [1]. So, im-
provement in radiotherapy efficiency associated with reduction of early 
and late side effects of exposure to radiation are most important aims in 
this way. However, in recent years the increased life expectancy results 
in growing concerns related to long term consequences of radiotherapy 
including secondary malignancy. It may result in decline in the quality 
of life among patients who have undergone radiotherapy and also affect 
cost-effectiveness of radiotherapy, particularly pediatric patients [2, 3]. 
The perception of biological effects of ionizing radiation can help man-
age side effects of radiotherapy such as secondary cancers by selecting 
an appropriate radiation treatment modality. 
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ABSTRACT
Bystander or non-targeted effect is known to be an interesting phenomenon in radio-
biology. The genetic consequences of bystander effect on non-irradiated cells have 
shown that this phenomenon can be considered as one of the most important factors 
involved in secondary cancer after exposure to ionizing radiation. Every year, millions 
of people around the world undergo radiotherapy in order to cure different types of 
cancers. The most crucial aim of radiotherapy is to improve treatment efficiency by 
reducing early and late effects of exposure to clinical doses of radiation. Secondary 
cancer induction resulted from exposure to high doses of radiation during treatment 
can reduce the effectiveness of this modality for cancer treatment. The perception 
of carcinogenesis risk of bystander effects and factors involved in this phenomenon 
might help reduce secondary cancer incidence years after radiotherapy. Different mo-
dalities such as radiation LET, dose and dose rate, fractionation, types of tissue, gender 
of patients, etc. may be involved in carcinogenesis risk of bystander effects. Therefore, 
selecting an appropriate treatment modality may improve cost-effectiveness of radia-
tion therapy as well as the quality of life in survived patients. In this review, we first 
focus on the carcinogenesis evidence of non-targeted effects in radiotherapy and then 
review physical and biological factors that may influence the risk of secondary cancer 
induced by this phenomenon.
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Non-targeted or distant bystander effect is 
a phenomenon in radiotherapy which causes 
damage to non-irradiated cells in distant tis-
sues. The bystander effect is being observed in 
different cell types with different end points, 
especially carcinogenesis markers. This phe-
nomenon may lead to systemic effects in pa-
tients who have undergone local radiotherapy 
for a certain part of the body [4]. Moreover, 
it is reported that bystander effects may be 
linked to secondary cancers in patients who 
have undergone radiation treatment [5]. Carci-
nogenesis effects of bystander phenomenon in 
animal models have been confirmed. A study 
by Mancuso et al. demonstrates that partial 
irradiation can result in cancer induction in 
non-targeted tissues. They used a radiosen-
sitive Patched-1 (Ptch1) heterozygous mice 
model to evaluate genetic damage and the in-
duction of medulloblastoma in a non-targeted 
brain after the irradiation of mice with skull 
shield. Lower half of the body of mice was ir-
radiated (3 Gy of X-rays) while upper organs 
were protected. The results showed increased 
medulloblastoma rate in non-targeted brains. 
Increased risk of carcinogenesis was associ-
ated with chromosome damage and apoptosis 
in non-targeted cerebellums [6]. Considering 
the pivotal role of bystander effects in risk of 
secondary carcinogenesis, efforts to under-
stand the basic mechanisms and modulate the 
genetic damages induced by this phenomenon 
may provide new approaches to cancer man-
agement.
Evidence for the High Incidence of 
Secondary Cancers in Out-of-field 
Organs
Based on cellular and molecular effects in-
vestigated with the bystander effect, there are 
concerns related to the incidence of secondary 
cancers following radiotherapy. To select the 
most appropriate treatment method, the aware-
ness of the probability of secondary malignan-
cies after treatment should be heightened. The 
increased risk of secondary cancers reduces 
the weight of benefits of radiation therapy 
against the adverse effects. Probably, the best 
example for the involvement of the bystander 
effect in cancer induction is high incidence of 
lung cancer among patients who have had ex-
ternal radiotherapy and brachytherapy due to 
the treatment of pelvis cancers such as pros-
tate, ovarian and rectal cancers. Induction of 
second cancers were obvious particularly for 
long term survivors [7].
In addition to in-field secondary cancers, 
Bostrom et al. declared an increase in second-
ary cancers in out-of-field area after radiother-
apy for cancers such as lung, sarcomas and 
melanoma [8]. Moreover, Joung et al. con-
tended the increased frequency of out-of-field 
cancers after radiotherapy for prostate cancer 
the same as esophagus, stomach, liver, pancre-
as, larynx, lung, bronchus and thyroid cancers. 
These results were obtained from follow-up 
of 55,378 men diagnosed with primary pros-
tate cancer [9]. Brenner et al. compared sec-
ondary cancer induction in 51,584 men with 
prostate cancer who underwent radiotherapy 
and 70,539 men who underwent surgery with-
out radiotherapy. They proclaim that the most 
prevalent secondary cancers among the irradi-
ated group compared to the surgery group are 
bladder, rectum and lung cancers [10]. 
The increased risk of lung cancer is also re-
ported after radiotherapy for cervical cancer, 
in a cohort comprising 86,193 patients. While, 
the reported average radiation dose received 
by lung tissue during radiotherapy for cervi-
cal cancer had 0.1 Gy, the second excessive 
lung cancer, which is anatomically distant 
from the irradiated organs including half of 
excess cancers; although, authors proposed 
possible roles of smoking for increased lung 
cancer in this cohort study [11]. The analysis 
of the frequency of secondary malignancies 
in patients who have undergone radiotherapy 
for rectal cancer showed a significant increase 
in secondary cancers in in-field-of-treatment 
organs, and also out-of-field organs such as 
lungs, the stomach and the colon. The radia-
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tion doses received by such organs were very 
low compared to the doses received by in-field 
of treatment organs. The authors state that the 
explanation for increased cancers induction in 
out-of-field organs considering the received 
doses is not obvious [12]. It seems that risk of 
secondary cancer induced by scattered radia-
tion in out-of-field organs is negligible, and in-
creased cancer induction in out-of-field organs 
results in biological pathways [13].
Role of Irradiation Modalities on 
Bystander Responses
Nowadays, radiotherapy is used to treat 
many different cancers with high dose rates 
and heavy particles. Moreover, several new 
centers equipped with heavy ion accelerators 
are under way, But, cost-effectiveness and risk 
of secondary malignancies for these radiation 
modalities are open to debate. The bystander 
effect as a phenomenon involved in secondary 
cancer induction is likely to be the key factor 
in the selection of an appropriate modality for 
cancer treatment.
Radiation Quality
Although for the first time the non-targeted 
effects of ionizing radiation were investigated 
after local irradiation of protons, it quickly 
was demonstrated that this phenomenon could 
be induced by different radiation qualities. 
The perception of the effects of radiation qual-
ity on bystander cells is crucial to predict the 
radiation risks such as carcinogenesis associ-
ated with cancer radiotherapy by heavy ions 
and also space exploration [4]. 
The results of some studies on various quali-
ties of radiation have confirmed that the by-
stander effect depends on the quality of radia-
tion. The evaluation of bystander effects in 
human lymphocytes co-cultured with macro-
phages, irradiated with heavy carbon ions or 
γ-rays revealed more persistent upregulation 
of MAPKs in bystander cells [14]. Chronic 
oxidative damage and micronuclei formation 
were investigated for 20 population doublings 
of cells co-culture with cells that had been 
exposed to 56Fe and 600 MeV/u 28Si ions. 
However, it was not observed for lower LET 
radiation including 1 GeV proton ions. Chron-
ic oxidative damage in progeny cells may be 
related to the function of respiratory chain 
complexes and the suppression of antioxidant 
enzymes including catalase (CAT), glutathi-
one peroxidase (GSH-Px) and superoxide dis-
mutase (SOD) activities [15]. In another study, 
the results of the comparison of micronucleus 
formation with X-ray, and carbon, neon and 
argon ions have shown that the number of mi-
cronuclei in bystander cells was greater for 
higher LET. Furthermore, it should be point-
ed that micronucleus formation occurred in a 
dose-dependent manner for all radiation quali-
ties [16]. 
Anzenberg et al. evaluated the surviving 
fraction, γ-H2AX focus and micronuclei for-
mation after irradiation with 250 kVp X-rays 
or α particles. The results exhibited greater 
γ-H2AX foci per nucleus and more obvious 
decrease in the surviving fraction after irra-
diation with X-ray compared to α particles 
[17]. Besides, it was investigated that oxida-
tive damage and mutation in the progeny of 
bystander cells have a negative relationship to 
the quality of radiation. In a study, it was con-
cluded that the next generation of bystander 
cells irradiated with X-rays and protons bears 
persistent oxidative stress, albeit it was not ob-
served on cells irradiated by carbon ions [18].
Dose and Dose Rate Effects
In radiation therapy, irradiation with differ-
ent dose rates such as brachytherapy, 60CO, 
LINAC, etc. is used to treat cancer. Each of 
these modalities contributes to different ra-
diation doses received by normal tissues. So, 
use of each radiation treatment modality may 
lead to different damage levels in distant non-
targeted tissues. The results are obtained from 
a study in which the bystander effect was in-
vestigated by different radiation doses and 
dose rates including external or radioactive 
seeds [19]. Liu et al. evaluated dose threshold 
for induction of the bystander effect in human 
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skin cell lines. Cells were irradiated in the 
range of 0.04 mGy-5 Gy, and then medium 
was transferred to non-irradiated cells. The re-
sults showed a dose threshold around 2 mGy 
for a change in cell survival and calcium flux. 
However, below that dose, survival fraction 
increased in bystander cells [20].
Gow et al. evaluated the effect of different 
dose rates of 60Co and 20 MeV electron irradi-
ations in bystander responses to HPV-G cells. 
The dose rates included 1.1, 1.7, 3 and 4.7 Gy/
min at different radiation doses; 0.5, 5 and 
10Gy. The results did not show any significant 
differences in the survival fraction between 
different dose rates of 60Co. Besides, for 20 
MeV electron, the effect of dose rate was in-
vestigated only for 10Gy, not for lower doses. 
Interestingly, cells that received medium from 
cells irradiated with 10Gy showed higher sur-
vival fractions. The authors proposed that it 
might be related to larger amounts of growth 
factors such as TGFβ that they stimulate cell 
proliferation, resulting in increase in survival 
fractions [21]. In very low and high doses, it 
seems that radiation bystander signals stimu-
late proliferation, but in other doses usually 
used in clinical applications, the bystander ef-
fect has a negative effect on cells. Therefore, 
such results indicate that the effect of radiation 
dose is deemed to be more substantial when 
compared to the dose rate.
Fractionation Effect
Mothersill et al. evaluated the effects of frac-
tionation on bystander cells. They proved that 
the effect of fractionated irradiation was more 
obvious compared to the effect of a single 
dose. These results suggest that although the 
fractionated radiotherapy bears less toxicity 
to normal tissues which have received direct 
exposure, distant cells that received bystand-
er signals from the irradiated tissue, are at a 
greater risk of carcinogenesis compared to 
single irradiation. This effect would attenuate 
sparing effects of the fractionated radiothera-
py and may reduce the therapeutic ratio [22]. 
Another study did not show any differenc-
es in the frequency of micronucleus between 
a single acute dose and the fractionated one 
[23]. It is proposed that the effect of fraction-
ation on the bystander effect response hinges 
on the radiation dose and seems to be obvious 
in higher doses [24]. In this case, in-vivo stud-
ies are very limited. Ilnytskyy et al. studied 
the effect of both acute and fractionation irra-
diation on the bystander effect in mice model 
study. They investigated that the skull irra-
diation with single or two-fractionated expo-
sure results in similar DNA hypomethylation 
in the spleen. The results showed that dose-
fractionation did not decrease DNA damage 
and long-term changes of DNA methylation 
compared to single irradiation [25]. As the by-
stander effect depends on the type of cell, the 
experimental design and the culture media, it 
is predictable that different studies yield vari-
ous results. Moreover, most of these results 
are based on in-vitro studies and need to be 
approved by in-vivo experiments.
Sex Specificity of the Bystander 
Effect
Several years ago, studies demonstrated 
radiation-sensitivity is likely to be a phenom-
enon based on sex specificity [26]. A remark-
able body of research has demonstrated the 
role of sex in DNA damage and subsequent 
consequences. Evidence has shown that pat-
terns of gene expression, epigenetic changes 
and also secondary cancers induced by ioniz-
ing radiation occur on different frequencies in 
males and females [27-30]. For the first time, 
Korturbash et al. have shown that local cranial 
irradiation of mice results in a sex-dependent 
induction of DNA damage and alterations in 
global DNA methylation in spleen. It is con-
firmed that loss of DNA methylation is as-
sociated with genome rearrangements and 
increased risk of carcinogenesis. They investi-
gated that sex hormones are responsible for the 
induction of different responses in non-target-
ed spleen tissue. The evaluation of the levels 
of global cytosine DNA methylation indicated 
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a significant and persistent hypomethylation 
in direct irradiated and the non-targeted spleen 
of male mice at 4 and 96 hours after exposure. 
In females, hypomethylation was less pro-
nounced and seen only 96 hours after direct 
irradiation of whole body. The results showed 
sex specificity for proliferation and apoptosis 
induced by the irradiation of whole body and 
non-targeted effects [31]. 
Moreover, miRNA microarray analysis has 
revealed that the deregulation of microR-
NAome in the spleen tissue follows whole 
body or cranial irradiation. The results showed 
downregulation of 6 microRNAs in male 
mice, upregulation and downregulation of 3 
and 6 microRNAs, respectively in females, 
thereby, confirming the role of sex hormones 
in the deregulation of microRNAome [32]. 
Accordingly, following studies confirmed that 
the induction of genes involved in redox sys-
tem such as TGFβ and COX-2 in male mice 
are higher compared to that in females [33-
34]. The upregulation of these genes results in 
the production of ROS and NO which leads to 
DNA damage and mutagenesis. However, risk 
of carcinogenesis after exposure to ionizing 
radiation based on sex is contradictory. Some 
studies have shown higher risk for females, 
while some have mentioned higher radiation 
sensitivity for male mice [35-37].
Tissue Specificity of the Bystander 
Effect
Different tissues have shown various re-
sponses to ionizing radiation. This difference 
is seen in both early and late effects of radia-
tion on normal tissues. Additionally, different 
sensitivity of organs leads to different carci-
nogenesis risks years after exposure [38]. Dif-
ferent effects induced by the bystander effect 
in different cell types have been observed in 
in-vitro studies [39-41]. In-vivo studies which 
have confirmed the expression of carcinogen-
esis markers in non-targeted tissues is deemed 
to be different. Tissue specificity in response 
to the bystander effect is related to the expres-
sion of bystander signals in non-irradiated 
tissues. So, this phenomenon may be inde-
pendent from radiation sensitivity of organs. 
The evaluation of DNA methylation changes 
in non-targeted tissues including the spleen 
and the skin has indicated distinct specificity 
at different times. The results showed that lo-
cal cranial irradiation can cause loss of DNA 
methylation in the skin only 6 hours after ex-
posure, not later hours. However, cranial ir-
radiation could lead to hypomethylation as-
sociated by the inhibition of methyl-binding 
protein MeCP2 expression in distant spleen 
tissue for 14 days after exposure [25].  
In addition to the role of epigenetic modu-
lators, tissue specificity of bystander effect is 
related to different expressions of genes in-
volved in reduction/oxidation (redox) system. 
As mentioned earlier, ROS/NO producing en-
zymes have a pivotal role in oxidative DNA 
damage and subsequent genomic instability in 
bystander cells. Different expressions of genes 
involved in redox systems which is related to 
bystander signals, result in different levels 
of oxidative damage in such tissues. COX-2 
is one of the ROS producing enzymes which 
plays a crucial role in oxidative damage in by-
stander cells. While COX-2 is not expressed 
in all types of cells and also the basal level 
of COX-2 expression is low, in response to 
bystander signals, the production of this en-
zyme rises more obviously [42]. In-vivo stud-
ies showed that partial irradiation of abdomen 
leads to increased expression of COX-2 by 
more than 20-fold in lung and 30-fold in lung 
bronchial epithelial cells relevant to the con-
trol level. The results indicated no significant 
induction of COX-2 expression and mutagen-
esis in liver [33, 43].
Carcinogenesis Markers in Non-tar-
geted Cells
Bystander effect is mediated with mecha-
nisms that produces free radicals or change 
DNA integrity. Role of ROS/NO producing en-
zymes in oxidative DNA damage in bystander 
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cells has been confirmed [44, 45]. Moreover, 
the suppression of antioxidant enzymes ag-
gravates oxidative stress in non-targeted cells 
[46]. In other words, epigenetic modulators 
such as microRNAs change the expression of 
genes involved in cellular processes such as 
stress response which might increase the risk 
of carcinogenesis.
Free Radical Production
Ionizing radiation can stimulate different 
enzymes that produce ROS or NO. Most of 
these enzymes are immune mediators that kill 
microorganisms or stimulate inflammatory re-
sponses. Upregulation of these inflammatory 
enzymes such as COX-2, iNOS and NADPH 
Oxidase is an important marker for increased 
risk of carcinogenesis [47, 48]. Through in-
flammatory cytokines such as IL-1, IL-2, IL-
8, IL-33 and TNFα and anti-inflammatory 
cytokines such as TGFβ, the bystander effect 
stimulates the production of ROS/NO produc-
ing enzymes [49]. In addition, a mitochon-
drial function changes and amplifies oxidative 
damage induced by inflammatory responses 
[50, 51]. Continuous free radical production 
results in oxidative damage to critical targets 
such as DNA, lipids and proteins. Oxidative 
damage changes normal functions of these 
biomolecules that may lead to increased risk 
of carcinogenesis.
Inhibition of Antioxidant Enzymes
Cells develop both enzymatically and non-
enzymatically antioxidant defense systems 
against detrimental potentials of ROS and 
RNS. These antioxidant systems consist of 
low molecular weight such as glutathione 
(GSH) and antioxidant enzymes such as SOD, 
CAT and GSH-Px. The suppression of these 
antioxidant defense systems is one of the most 
substantial mechanisms involved in radiation 
toxicity that can result in chronic oxidative 
damage, genomic instability and interruption 
of normal structure of tissues [52-54]. Some 
studies have shown that the inhibition of an-
tioxidant system activity has a key role in the 
increased ROS levels and the oxidative stress 
in non-irradiated bystander cells. Najafi et al. 
exhibited that local irradiation of rat pelvis 
with 3Gy gamma rays resulted in a remarkable 
oxidative damage to lung tissue. The results 
indicated a dramatic decline in SOD activity 
at 24th and 72nd hours after local irradiation, 
while direct irradiation increased SOD activ-
ity at mentioned times. Furthermore, the levels 
of GSH in non-targeted lung tissues reduced at 
the 24th hour after exposure, while direct irra-
diation did not decrease GSH at the mentioned 
times [46].
Further researches have proposed the role 
of epigenetic modulators in the suppression 
of SOD activity. Epigenetic mediators such as 
miR-21 affect ROS generation and suppres-
sion of SOD activity in bystander cells. Xu et 
al. revealed that the upregulation of miR-21 is 
involved in micronuclei formation and 53BP1 
foci in bystander cells [55]. Tian and col-
leagues showed that miR-21 increases ROS 
production through inhibition of MnSOD [56]. 
Another study showed that the upregulation of 
TGF-β is responsible for MnSOD suppression 
and the increased ROS levels [57]. Targeting 
TGF-β decreases 53BP1 foci and micronuclei 
formation in bystander cells [58].
Upregulation of Oncogenes
Oncogenes are genes involved in cell prolif-
eration and are held potential to promote ma-
lignancy. These genes are often changed and 
expressed at abnormal levels in tumor cells. 
Upregulation of oncogenes through suppres-
sion of DNA methylation is considered as a 
vital mechanism for carcinogenesis effect of 
bystander effect. It seems that miRNAs play 
a pivotal role in the expression of DNA meth-
yltransferases (DNMT) genes, especially DN-
MT3a, DNMT3b, and subsequent hypometh-
ylation [59]. Upregulation or downregulation 
of some miRNAs can cause changes in the 
expression of oncogenes through hypometh-
ylation [60]. It is confirmed that miRNAs are 
involved in the regulation of RAS oncogene 
and cellular proliferation [61]. Sedelnikova 
et al. indicated an increased level of DNA 
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damage associated with loss of nuclear DNA 
methylation after exposure to radiation [62]. 
Koturbash et al. showed that local cranial ir-
radiation results in over-expression of miR-
194 which leads to inhibition of DNMT3a and 
methyl-binding protein methyl CpG binding 
protein 2 [MeCP2] in the distant spleen tissue. 
These changes contribute to the long term loss 
of genome DNA methylation that might lead 
to genomic instability [63].
Genomic Instability
Genomic instability is a phenomenon seen 
almost in all human cancers. This phenomenon 
causes chromosomal alterations in cells such 
as abnormal frequency of mutations within the 
genome, mutations in tumor suppressor and 
DNA repair genes, loss of DNA methylation 
and histone modifications, alteration in mi-
tochondrial DNA and energy balance within 
cells, attenuation of antioxidant enzymes and 
so on [64-70]. These changes have been seen 
in long periods after exposure in direct irradi-
ated and bystander cells [71, 72]. For the first 
time, Lorimore and colleagues have observed 
the occurrence of genomic instability markers 
in the progeny of bystander cells [73]. Sey-
mour et al. showed that the transferred medi-
um from irradiated human epithelial cells can 
induce genomic instability in the progeny of 
bystander cells. They investigated that these 
cells show a reduced plating efficiency [74]. 
Other studies have shown increased apopto-
sis, mutations, deletion, abnormal gene am-
plification and allelic imbalance for both low 
and high LET radiations [75-77]. It is possible 
that persistent ROS production, inhibition of 
antioxidant enzymes and epigenetic changes 
stimulate continues mutation and induce ge-
nomic instability.
The Bystander Effect May Increase 
Carcinogenesis Risk in Next Gen-
erations of Irradiated People
For long years, there have been concerns 
for heritable effects of ionizing radiation, es-
pecially carcinogenesis. Evidence has shown 
that clastogenic factors induced by ionizing 
radiation can cause genomic mutation in by-
stander cells and their offspring. It indicates 
that genomic mutation induced by bystander 
effects in germ cells is able to be transferred to 
next generations. Evidence has demonstrated 
that genomic instability in germ cells can lead 
to stable chromosomal abnormalities and be 
transferred to the second generation [78, 79]. 
Evidence also reveals that genome instability 
and epigenetic changes such as altered miR-
NA expression in the germline cells have an 
important role in transgenerational effects of 
radiation. The effects have been considered as 
upregulation of miR-709, miR-29a and miR-
29b, inhibition of DNMT3a and Brother of the 
Regulator of Imprinted Sites (BORIS), and 
also obvious hypomethylation of transposable 
elements such as LINE1 and SINE B2 [80-83]. 
In an in-vivo study, the bystander effect 
has been deemed as a mechanism involved 
in radiation induced genomic instability and 
transgenerational effects of ionizing radiation. 
Tamminga et al. showed that local cranial ir-
radiation in rat results in unrepaired DNA 
damage in the sperm cells and subsequent 
transgenerational genomic instability, and 
an obvious epigenetic dysregulation in their 
progeny. The results additionally indicated a 
significant hypomethylation in the bone mar-
row, thymus and spleen of the second genera-
tion of exposed animals [84]. These changes 
are likely to be related to increased risk of car-
cinogenesis such as hematopoietic malignan-
cies in progeny of irradiated people [85-88].
Conclusion
While the increased survival of patients who 
have undergone radiotherapy is an incredible 
success in cancer treatment, there are concerns 
related to the increased risk of secondary ma-
lignancies especially for long years after ther-
apy. Evidence proves that cancer induction in 
out-of-field organs is the undeniable part of 
secondary cancers. Studies have admitted the 
role of the bystander effect in cancer induction 
441
J Biomed Phys Eng 2018; 8(4)
www.jbpe.orgYahyapour R. et al
after exposure to radiation. So, attention to this 
phenomenon is very critical for the evaluation 
and selection of most appropriated treatment 
modalities. It seems that the effect of radiation 
modalities on bystander damage is different 
compared to directly irradiated cells.
Based on some studies, it seems that DNA 
damage induced by bystander signaling in 
non-targeted cells and also its progenies are 
evaluated less than the irradiation with pro-
ton particles compared to lower or higher ra-
diation qualities. It may indicate a beneficial 
effect of proton therapy compared to x-ray 
radiotherapy. Interestingly, fractionated irradi-
ation has shown higher damages to bystander 
cells in comparison with acute single irradia-
tion. Fractionation is a conventional method in 
radiotherapy to ameliorate the acute effects of 
exposure to radiation doses which is necessary 
to kill tumor cells. In contrast to directly irra-
diated cells, fractionation causes higher toxic-
ity to bystander cells. It possibly reduces the 
beneficial effects of fractionated radiotherapy. 
Similar to fractionation, the effect of dose and 
dose rate on bystander cells are different com-
pared to directly irradiated demonstrate. Some 
result did not show any effects for different 
dose rates. Besides, some studies have shown 
contradictory results suggesting that it might 
be related to the role of growth factors in by-
stander cells. 
According to different expressions of genes 
involved in the bystander effect in different 
cell types, it is predictable that genetic dam-
age and genomic instabilities are different 
among tissues. It results in different suscep-
tibilities to carcinogenesis in various organs. 
Furthermore, carcinogenesis susceptibility 
among non-targeted tissues differs from ra-
diation sensitivity. Genetic mutation in males 
is different from that in females. Similar to 
directly irradiated tissues, DNA damage and 
subsequent consequences are more obvious in 
males compared to females. However, some 
studies have shown a higher risk of carcino-
genesis after exposure for women compared 
to men.
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